z-logo
open-access-imgOpen Access
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
Author(s) -
Neal M. Patel,
Kian Bichoupan,
Lawrence Ku,
Rachana Yalamanchili,
Alyson Harty,
Donald Gardenier,
Michel Ng,
David Motamed,
Viktoriya Khaitova,
Nancy Bach,
Charissa Chang,
Priya Grewal,
Meena B. Bansal,
Ritu Agarwal,
Lawrence Liu,
Gene Y. Im,
Jennifer Leong,
Leona KimSchluger,
Joseph A. Odin,
Jawad Ahmad,
Scott L. Friedman,
Douglas T. Dieterich,
Thomas D. Schiano,
Ponni V. Perumalswami,
Andrea D. Branch
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i9.2844
Subject(s) - medicine , sofosbuvir , interquartile range , decompensation , liver transplantation , gastroenterology , adverse effect , cumulative incidence , cirrhosis , hepatitis c , transplantation , regimen , incidence (geometry) , surgery , hepatitis c virus , ribavirin , immunology , virus , physics , optics
To determine the safety profile of new hepatitis C virus (HCV) treatments in liver transplant (LT) recipients with recurrent HCV infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom